Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Ginkgo Bioworks Holdings, Inc.DNA · Entity 5530 | See remarks | October 05, 2026 | October 07, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Ginkgo Bioworks Holdings, Inc.
Report date October 05, 2026 · Filed October 07, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 49,448 |
Reported balance
After 2026-10-05 transaction · row 1
1 source rowRow 1 · 2026-10-05 · Sale · Disposed 2,403 · Balance 49,448 F1: The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934 |
Filing footnotes · ownership attribution and instrument terms
F1: The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 01, 2024 Filed Nov 6, 2024 21:29 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 587 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-026591 · form4.xml · nonDerivative · entry 1 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,633 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
| October 04, 2024 Filed Oct 8, 2024 20:27 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 306 | $8.35 | $2,555.41 |
DisclosureSEC source: 0001127602-24-025334 · form4.xml · nonDerivative · entry 3 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,046 F2 · kind: Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock and/or restricted stock units. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| October 03, 2024 Filed Oct 8, 2024 20:27 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionRestricted Stock Units · Derivative | 156 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-025334 · form4.xml · derivative · entry 5 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,407 Underlying: Class A Common Stock · 156 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F4 · derivative.exercise_date: The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter. F4 · derivative.expiration_date: The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter. Read SEC document |
| October 03, 2024 Filed Oct 8, 2024 20:27 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionRestricted Stock Units · Derivative | 587 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-025334 · form4.xml · derivative · entry 4 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,210 Underlying: Class A Common Stock · 587 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F3 · derivative.exercise_date: The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter. F3 · derivative.expiration_date: The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter. Read SEC document |
| October 03, 2024 Filed Oct 8, 2024 20:27 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 156 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-025334 · form4.xml · nonDerivative · entry 2 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,352 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
| October 03, 2024 Filed Oct 8, 2024 20:27 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 587 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-025334 · form4.xml · nonDerivative · entry 1 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,196 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
| September 12, 2024 Filed Sep 16, 2024 20:28 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 316 | $6.17 | $1,950.35 |
DisclosureSEC source: 0001127602-24-024002 · form4.xml · nonDerivative · entry 3 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,609 F3 · kind: Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock and/or restricted stock units. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. F2 · balance_after: This amount reflects the 1-for-40 reverse stock split effected by the Issuer on August 20, 2024. Read SEC document |
| September 11, 2024 Filed Sep 16, 2024 20:28 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionRestricted Stock Units · Derivative | 156 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-024002 · form4.xml · derivative · entry 5 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,563 Underlying: Class A Common Stock · 156 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F5 · derivative.exercise_date: The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter. F5 · derivative.expiration_date: The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter. F2 · balance_after: This amount reflects the 1-for-40 reverse stock split effected by the Issuer on August 20, 2024. Read SEC document |
| September 11, 2024 Filed Sep 16, 2024 20:28 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionRestricted Stock Units · Derivative | 587 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-024002 · form4.xml · derivative · entry 4 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,797 Underlying: Class A Common Stock · 587 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F4 · derivative.exercise_date: The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter. F4 · derivative.expiration_date: The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter. F2 · balance_after: This amount reflects the 1-for-40 reverse stock split effected by the Issuer on August 20, 2024. Read SEC document |
| September 11, 2024 Filed Sep 16, 2024 20:28 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 156 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-024002 · form4.xml · nonDerivative · entry 2 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,925 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F2 · balance_after: This amount reflects the 1-for-40 reverse stock split effected by the Issuer on August 20, 2024. Read SEC document |
| September 11, 2024 Filed Sep 16, 2024 20:28 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 587 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-024002 · form4.xml · nonDerivative · entry 1 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,769 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F2 · balance_after: This amount reflects the 1-for-40 reverse stock split effected by the Issuer on August 20, 2024. Read SEC document |
| August 02, 2024 Filed Aug 6, 2024 20:39 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 17,486 | $0.29 | $5,018.48 |
DisclosureSEC source: 0001127602-24-021720 · form4.xml · nonDerivative · entry 3 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 207,318 F2 · kind: Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock and/or restricted stock units. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| August 01, 2024 Filed Aug 6, 2024 20:39 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionRestricted Stock Units · Derivative | 6,250 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-021720 · form4.xml · derivative · entry 5 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 268,751 Underlying: Class A Common Stock · 6,250 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F4 · derivative.exercise_date: The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter. F4 · derivative.expiration_date: The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter. Read SEC document |
| August 01, 2024 Filed Aug 6, 2024 20:39 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionRestricted Stock Units · Derivative | 23,496 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-021720 · form4.xml · derivative · entry 4 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 775,377 Underlying: Class A Common Stock · 23,496 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F3 · derivative.exercise_date: The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter. F3 · derivative.expiration_date: The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter. Read SEC document |
| August 01, 2024 Filed Aug 6, 2024 20:39 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 6,250 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-021720 · form4.xml · nonDerivative · entry 2 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 224,804 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
| August 01, 2024 Filed Aug 6, 2024 20:39 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 23,496 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-021720 · form4.xml · nonDerivative · entry 1 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 218,554 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
| July 02, 2024 Filed Jul 5, 2024 20:02 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 13,520 | $0.33 | $4,407.52 |
DisclosureSEC source: 0001127602-24-020165 · form4.xml · nonDerivative · entry 3 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 195,058 F2 · kind: Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock and/or restricted stock units. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| July 01, 2024 Filed Jul 5, 2024 20:02 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionRestricted Stock Units · Derivative | 6,250 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-020165 · form4.xml · derivative · entry 5 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 275,001 Underlying: Class A Common Stock · 6,250 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F4 · derivative.exercise_date: The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter. F4 · derivative.expiration_date: The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter. Read SEC document |
| July 01, 2024 Filed Jul 5, 2024 20:02 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionRestricted Stock Units · Derivative | 23,496 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-020165 · form4.xml · derivative · entry 4 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 798,873 Underlying: Class A Common Stock · 23,496 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F3 · derivative.exercise_date: The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter. F3 · derivative.expiration_date: The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter. Read SEC document |
| July 01, 2024 Filed Jul 5, 2024 20:02 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 6,250 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-020165 · form4.xml · nonDerivative · entry 2 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 208,578 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
| July 01, 2024 Filed Jul 5, 2024 20:02 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 23,496 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-020165 · form4.xml · nonDerivative · entry 1 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 202,328 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 21:06 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 13,440 | $0.55 | $7,378.56 |
DisclosureSEC source: 0001127602-24-017961 · form4.xml · nonDerivative · entry 3 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 178,832 F2 · kind: Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock and/or restricted stock units. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| May 31, 2024 Filed Jun 5, 2024 21:06 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionRestricted Stock Units · Derivative | 6,249 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-017961 · form4.xml · derivative · entry 5 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 281,251 Underlying: Class A Common Stock · 6,249 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F4 · derivative.exercise_date: The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter. F4 · derivative.expiration_date: The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter. Read SEC document |
| May 31, 2024 Filed Jun 5, 2024 21:06 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionRestricted Stock Units · Derivative | 23,496 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-017961 · form4.xml · derivative · entry 4 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 822,369 Underlying: Class A Common Stock · 23,496 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F3 · derivative.exercise_date: The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter. F3 · derivative.expiration_date: The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter. Read SEC document |
| May 31, 2024 Filed Jun 5, 2024 21:06 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 6,249 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-017961 · form4.xml · nonDerivative · entry 2 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 192,272 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
| May 31, 2024 Filed Jun 5, 2024 21:06 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 23,496 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-017961 · form4.xml · nonDerivative · entry 1 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 186,023 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
| May 02, 2024 Filed May 6, 2024 20:53 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 131,928 | $0.85 | $111,479.16 |
DisclosureSEC source: 0001127602-24-014296 · form4.xml · nonDerivative · entry 3 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 162,527 F2 · kind: Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock and/or restricted stock units. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| May 01, 2024 Filed May 6, 2024 20:53 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionRestricted Stock Units · Derivative | 12,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-014296 · form4.xml · derivative · entry 5 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 287,500 Underlying: Class A Common Stock · 12,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F4 · derivative.exercise_date: The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter. F4 · derivative.expiration_date: The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter. Read SEC document |
| May 01, 2024 Filed May 6, 2024 20:53 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionRestricted Stock Units · Derivative | 281,955 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-014296 · form4.xml · derivative · entry 4 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 845,865 Underlying: Class A Common Stock · 281,955 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F3 · derivative.exercise_date: The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter. F3 · derivative.expiration_date: The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter. Read SEC document |
| May 01, 2024 Filed May 6, 2024 20:53 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 12,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-014296 · form4.xml · nonDerivative · entry 2 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 294,455 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
| May 01, 2024 Filed May 6, 2024 20:53 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 281,955 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-014296 · form4.xml · nonDerivative · entry 1 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 281,955 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
| March 07, 2024 Filed Mar 8, 2024 21:56 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | GrantRestricted Stock Units · Derivative | 300,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-009217 · form4.xml · derivative · entry 1 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 300,000 Underlying: Class A Common Stock · 300,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F2 · derivative.exercise_date: The RSUs vest as follows: 2/48ths of the underlying shares on May 1, 2024, then 46 equal monthly installments thereafter. F2 · derivative.expiration_date: The RSUs vest as follows: 2/48ths of the underlying shares on May 1, 2024, then 46 equal monthly installments thereafter. Read SEC document |
| July 28, 2023 Filed Jul 28, 2023 21:08 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | GrantRestricted Stock Units · Derivative | 1,127,820 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-021537 · form4.xml · derivative · entry 1 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,127,820 Underlying: Class A Common Stock · 1,127,820 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F2 · derivative.exercise_date: The RSUs vest as follows: 25% of the underlying shares on May 1, 2024, then 36 equal monthly installments thereafter. F2 · derivative.expiration_date: The RSUs vest as follows: 25% of the underlying shares on May 1, 2024, then 36 equal monthly installments thereafter. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.